Follicular lymphoma, unspecified, intrapelvic lymph nodes
ICD-10 C82.96 is a billable code used to indicate a diagnosis of follicular lymphoma, unspecified, intrapelvic lymph nodes.
Follicular lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of B-lymphocytes in a follicular pattern. This specific code, C82.96, refers to cases where the lymphoma is located in the intrapelvic lymph nodes but is unspecified in terms of histological subtype or other characteristics. Follicular lymphoma typically presents in stages I to IV, with staging based on the Ann Arbor classification system, which considers the number of lymph node regions involved and the presence of systemic symptoms. B-symptoms, which include fever, night sweats, and unexplained weight loss, may be present and can influence treatment decisions. Treatment protocols often involve a combination of chemotherapy, immunotherapy, and, in some cases, radiation therapy, tailored to the individual patient’s disease stage and overall health. The prognosis varies, with many patients experiencing a chronic course of the disease, necessitating ongoing monitoring and management.
Detailed pathology reports, imaging studies, and treatment plans.
Diagnosis and management of newly diagnosed follicular lymphoma, monitoring of treatment response.
Ensure accurate staging and documentation of B-symptoms for treatment planning.
Imaging reports detailing lymph node involvement and any changes over time.
Imaging studies to assess lymph node enlargement or response to therapy.
Clear documentation of imaging findings related to intrapelvic lymph nodes.
Used for patients receiving chemotherapy for follicular lymphoma.
Document the specific chemotherapy regimen and patient response.
Oncology specialists should ensure accurate coding of chemotherapy administration.
Common treatments include chemotherapy, immunotherapy, and radiation therapy, often tailored to the patient's disease stage and overall health.
